DR. ANITA KOSZYK-SZEWCZYK M.D. NPI 1487871786

NPI Information

  • NPI: 1487871786
  • Provider Name: DR. ANITA KOSZYK-SZEWCZYK, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 695 S DOBSON RD
    CHANDLER, AZ
    ZIP 85224
  • Phone: (480) 821-2838

Map and Directions

Get Directions

NPI Details

DR. Anita Koszyk-szewczyk, M.D. is a hematology and oncology internal medicine in Chandler, AZ with 24 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Anita Koszyk-szewczyk, M.D. NPI is 1487871786. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

695 S DOBSON RD
CHANDLER, AZ
ZIP 85224-665
Phone: (480) 821-2838
Fax: (480) 821-9444

The NPI 1487871786 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Unclassified drugs (HCPCS:J3490)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Blood creatinine level (HCPCS:82565)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Ct scan of soft tissue of neck with contrast (HCPCS:70491)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)

The enumeration date for this NPI number is 4/19/2007 and was last updated on 11/15/2022.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology41606ARIZONAYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.